Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT00030537 · COMPLETED
Trial details
- NCT number
- NCT00030537
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.